Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 0.702 EUR Market Closed
Market Cap: 92.9m EUR
Have any thoughts about
Transgene SA?
Write Note

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 2.992 EUR with a low forecast of 2.222 EUR and a high forecast of 4.2 EUR.

Lowest
Price Target
2.222 EUR
217% Upside
Average
Price Target
2.992 EUR
326% Upside
Highest
Price Target
4.2 EUR
498% Upside
Transgene SA Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
4% Downside
PTCT
PTC Therapeutics Inc
2% Upside
TWST
Twist Bioscience Corp
13% Upside
ACAD
ACADIA Pharmaceuticals Inc
52% Upside
214450
PharmaResearch Co Ltd
12% Upside
300685
Amoy Diagnostics Co Ltd
30% Upside
1952
Everest Medicines Ltd
31% Downside
300896
Imeik Technology Development Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 3 years is 15%.

-3%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
2.992 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 2.992 EUR with a low forecast of 2.222 EUR and a high forecast of 4.2 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 3 years is 15%.

Back to Top